At the heart of the Oncology Voice Network (OVN) is a powerful mission: to unify oncology leaders across disciplines and accelerate the development of solutions that truly serve patients. Driving this mission are two trailblazers who have spent decades shaping the future of medical innovation—Dr. Ramin Farhood and Dr. Kirk Shepard.

Together, they bring unmatched expertise, global leadership, and a shared passion for breaking down barriers in oncology communication and collaboration.

Dr. Ramin Farhood, PharmD

Chief Executive Officer, OVN

Dr. Ramin Farhood is a distinguished pharmacologist and accomplished senior medical executive with over 20 years of global leadership in medical affairs. Known for his deep commitment to elevating the role of medical professionals within life sciences, Dr. Farhood has co-founded two key institutions that continue to shape the industry: the Medical Affairs Professional Society (MAPS) and the Immunoglobulin National Society (IgNS).

Throughout his career, he has held multiple high-impact roles in top pharmaceutical companies, steering strategic initiatives across global markets. His visionary thinking and ability to connect science with purpose earned him a coveted spot on Phar maVoice’s 100 Most Inspiring People in the Pharmaceutical Industry—a testament to his impact and leadership.

At OVN, Dr. Farhood leads with a clear goal: to build a platform where expertise, insight, and innovation converge to drive meaningful progress in oncology care.

Dr. Kirk Shepard, MD

Editor-in-Chief, Oncology Voice Network | Oncology Expert

A board-certified medical oncologist and hematologist, Dr. Kirk Shepard brings more than 25 years of experience in oncology, biotech, and pharmaceutical leadership. He has served as Chief Medical Officer (CMO) at multiple oncology-focused companies, guiding clinical strategy, product development, and patient engagement at the highest levels.

Dr. Shepard is widely recognized as a transformative voice in oncology—co-founding MAPS alongside Dr. Farhood to support the professional development of medical affairs leaders worldwide.

Named one of PharmaVoice’s 100 Most Inspiring People in the Pharmaceutical Industry, his dedication to patient-centered innovation and his ability to translate science into scalable impact continue to inspire his peers and teams.

As Editor-in-Chief of Voices of Oncology and co-leader of OVN, Dr. Shepard champions a collaborative approach to progress—ensuring that every voice in the oncology ecosystem has a place at the table.

🚀 A Shared Vision for the Future of Oncology

What unites Dr. Farhood and Dr. Shepard is not just their individual accomplishments—but their shared belief in the power of collaboration. With the launch of Voices of Oncology and the OVN platform, they are building a new kind of community: one that brings together physicians, scientists, industry leaders, and patient advocates to accelerate cancer cures through communication, insight, and trust.

As OVN continues to grow, its foundation will always be rooted in this leadership—visionary, experienced, and committed to pushing the field of oncology forward, together.